HRP20040944B1 - Medicaments containing betamimetic drugs and a novel anticholinesterase drug - Google Patents

Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Info

Publication number
HRP20040944B1
HRP20040944B1 HRP20040944A HRP20040944B1 HR P20040944 B1 HRP20040944 B1 HR P20040944B1 HR P20040944 A HRP20040944 A HR P20040944A HR P20040944 B1 HRP20040944 B1 HR P20040944B1
Authority
HR
Croatia
Prior art keywords
medicaments containing
novel
anticholinesterase drug
betamimetic
drugs
Prior art date
Application number
Other languages
English (en)
Inventor
Rolf Banholzer
Ingo Konetzki
Cristopher J Montague Meade
Helmut Meissner
Gerd Morschhaeuser
Michel Pairet
Michael A Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10256317A external-priority patent/DE10256317A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HRP20040944A2 publication Critical patent/HRP20040944A2/hr
Publication of HRP20040944B1 publication Critical patent/HRP20040944B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
HR20040944 2002-04-12 2004-10-11 Medicaments containing betamimetic drugs and a novel anticholinesterase drug HRP20040944B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (de) 2002-04-12 2002-12-03 Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum
PCT/EP2003/003669 WO2003087097A1 (de) 2002-04-12 2003-04-09 Arzneimittel enthaltend betamimetika und ein neues anticholinergikum

Publications (2)

Publication Number Publication Date
HRP20040944A2 HRP20040944A2 (en) 2005-04-30
HRP20040944B1 true HRP20040944B1 (en) 2012-12-31

Family

ID=29251756

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040944 HRP20040944B1 (en) 2002-04-12 2004-10-11 Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Country Status (19)

Country Link
EP (1) EP1497289B1 (xx)
JP (1) JP2005529111A (xx)
CN (1) CN1646527A (xx)
AT (1) ATE302774T1 (xx)
AU (1) AU2003232201B2 (xx)
BR (1) BR0309185A (xx)
CA (1) CA2481468C (xx)
DK (1) DK1497289T3 (xx)
ES (1) ES2248767T3 (xx)
HR (1) HRP20040944B1 (xx)
IL (1) IL164291A (xx)
MX (1) MXPA04009916A (xx)
NO (1) NO20044107L (xx)
NZ (1) NZ536337A (xx)
PL (1) PL213489B1 (xx)
PT (1) PT1497289E (xx)
RS (1) RS50735B (xx)
UY (1) UY27757A1 (xx)
WO (1) WO2003087097A1 (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
EP1577306A1 (de) * 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
US7244728B2 (en) 2004-03-17 2007-07-17 Boehringer Ingelheim International Gmbh Long acting betamimetics for the treatment of respiratory diseases
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
EA013405B1 (ru) 2005-02-25 2010-04-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Состав аэрозоля для дозирующих ингаляторов под давлением
KR20080036632A (ko) 2005-08-08 2008-04-28 아젠터 디스커버리 리미티드 바이시클로[2.2.1]헵트-7-일아민 유도체 및 이들의 용도
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
MX2016014399A (es) 2014-05-07 2017-01-20 Boehringer Ingelheim Int Nebulizador.
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
RS89804A (xx) 2006-10-27
ATE302774T1 (de) 2005-09-15
UY27757A1 (es) 2003-11-28
WO2003087097A1 (de) 2003-10-23
JP2005529111A (ja) 2005-09-29
ES2248767T3 (es) 2006-03-16
IL164291A (en) 2012-04-30
HRP20040944A2 (en) 2005-04-30
NZ536337A (en) 2007-05-31
CA2481468A1 (en) 2003-10-23
PT1497289E (pt) 2005-11-30
CN1646527A (zh) 2005-07-27
BR0309185A (pt) 2005-02-15
AU2003232201B2 (en) 2009-06-11
NO20044107L (no) 2004-11-04
IL164291A0 (en) 2005-12-18
CA2481468C (en) 2011-02-01
PL372450A1 (en) 2005-07-25
AU2003232201A1 (en) 2003-10-27
EP1497289A1 (de) 2005-01-19
EP1497289B1 (de) 2005-08-24
PL213489B1 (pl) 2013-03-29
DK1497289T3 (da) 2005-10-24
RS50735B (sr) 2010-08-31
MXPA04009916A (es) 2005-05-03

Similar Documents

Publication Publication Date Title
IL164291A0 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
WO2004037807A3 (en) Medicinal arylethanolamine compounds
UA86977C2 (ru) Производные гидантоина для лечения обструктивных болезней дыхательных путей
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
BR0009975B1 (pt) inalador de pà para um medicamento combinado.
MXPA06013221A (es) Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros.
YU84503A (sh) Upotreba azitromicina za pripremanje leka za lečenje neinfektivnih inflamatornih oboljenja
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
RS89904A (xx) Medikamenti koji sadrže steroide i novi lek antiholinesteraze
PL1643999T3 (pl) Pirydoksamina do zastosowania w leczeniu nefropatii cukrzycowej w cukrzycy typu II
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
IL170519A (en) Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
BR0307703A (pt) Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr
DE602004019096D1 (de) Medikamente zur inhalation mit betamimetika und einem anticholinergikum
DE50115277D1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
MY137679A (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
UY27686A1 (es) Nuevas sales del ácido cinámico, procedimientos para su preparación y su utilización como medicamentos.
LT2006026A (lt) 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimo pablogėjimui

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120327

Year of fee payment: 10

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20130410